glp-1 obesity drug news today 2025-10-20 2024 was a record year for trials and 2025 is already poised to take over GLP-1 Pharmacy Pricing Update (Dec

Acta Endocrinol (Buchar) 2020;16:275279

Some of the most compelling research: A study published in May 2026 in The Lancet looked at 108 Danish subjects with obesity and AUD who reported 17 days of heavy drinking on average over the last month

Reference: #DiabetesGuidelines #NICE2026 #Type2Diabetes #EvidenceBasedMedicine #Endocrinology #CardiometabolicHealth #SGLT2 #GLP1 To view or add a comment, sign in We are pleased to announce positive topline results from our Phase III clinical trial of zemprocitinib in patients with moderate-to-severe atopic dermatitis

Thomson, A

Ozempic is an injection that you give yourself once a week